Ryvu Therapeutics SA (RVU) — Cash Flow Quality Index
Ryvu Therapeutics SA (RVU) has a Cash Flow Quality Index of -0.22x as of March 2018. Operating cash flow of zł-4.33 Million is below net income of zł19.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Ryvu Therapeutics SA (RVU) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ryvu Therapeutics SA Cash Flow Quality Index (2014–2018)
Historical Cash Flow Quality Index for Ryvu Therapeutics SA across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check RVU cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Ryvu Therapeutics SA (2014–2018)
Year-by-year earnings quality comparison for Ryvu Therapeutics SA. For live market cap and the full company financial profile, see Ryvu Therapeutics SA market capitalisation.
| Year | Quality Index | Operating CF (PLN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | -40.80x | zł-36.42 Million | zł892.48K | ▼ -2601.3% |
| 2017 | 1.63x | zł10.98 Million | zł6.73 Million | ▲ +169.8% |
| 2016 | -2.34x | zł-6.28 Million | zł2.69 Million | ▲ +11.3% |
| 2015 | -2.64x | zł-16.43 Million | zł6.23 Million | ▼ -214.6% |
| 2014 | -0.84x | zł-4.90 Million | zł5.85 Million | — |